Skip to main content
. 2011 Nov 24;30(3):517–522. doi: 10.1016/j.vaccine.2011.11.063

Table 4.

MDCK 33016PF passages of field samples tested positive or questionable for respiratory tract viruses.

Viruses detected (no. of samples)
Original clinical sample 2nd passage MDCK 33016PF 3rd passage MDCK 33016PF
Enterovirus (16) None (15), Enterovirus (1, questionable) None (16)
Rhinovirus (12) None (12) nt
Coronavirus (9) None (8), Coronavirus (1, borderline) None (9)
Resp. Syncytial Virus (8) None (7), RSV (1, questionable) None (8)
Adenovirus (3) None (3) nt
Human metapneumovirus (3) None (3) nt
Parainfluenza virus (2) None (2) nt
Bocavirus (1) None (1) nt

Three double infections were counted individually. Maximum dilution of the original specimen for the 2nd passages was 2 × 104 3rd passage was done 1:10 from 2nd passage supernatant. nt: not tested.